Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy

Lignende værker

• Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
  af: Bogan, Richard K, et al.
  Udgivet: (2020)
• Time to Response with Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
  af: Bogan, Richard K., et al.
  Udgivet: (2015)
• Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
  af: Sarkanen, Tomi, et al.
  Udgivet: (2014)
• Sodium Oxybate for Narcolepsy with Cataplexy: Systematic Review and Meta-Analysis
  af: Alshaikh, Mashael K., et al.
  Udgivet: (2012)
• Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate
  af: Tomi eSarkanen, et al.
  Udgivet: (2014-08-01)